Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group

Randomized Controlled Study Comparing Efficacy and Toxicity of Weekly vs. 3-Weekly Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma

(2020) Devale Tousif et al.   Frontiers in Oncology

Predictive classifier for intensive treatment of head and neck cancer

(2020) Kaveh Zakeri et al.   CANCER

Role of chemotherapy in 5000 patients with head and neck cancer treated by curative surgery: A subgroup analysis of the meta-analysis of chemotherapy in head and neck cancer

(2019) Etienne Dauzier et al.   ORAL ONCOLOGY

Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial

(2018) Lionnel Geoffrois et al.   JOURNAL OF CLINICAL ONCOLOGY

Radiotherapy Alone or with Concomitant Daily Low-Dose Carboplatin in Locally Advanced, Unresectable Head and Neck Cancer: Definitive Results of a Phase III Study with a Follow-Up Period of up to Ten Years

(2018) Maria Grazia Ruo Redda et al.   TUMORI

Impact of missing individual patient data on 18 meta-analyses of randomised trials in oncology: Gustave Roussy experience

(2018) Florence Fayard et al.   BMJ Open

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial

(2018) Hisham Mehanna et al.   LANCET

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

(2018) Maura L Gillison et al.   LANCET

Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis

(2017) Benjamin Lacas et al.   LANCET ONCOLOGY

Long-term update of the 24954 EORTC phase III trial on larynx preservation

(2016) B. Henriques De Figueiredo et al.   EUROPEAN JOURNAL OF CANCER

Conventional radiotherapy versus concurrent chemoradiotherapy versus accelerated radiotherapy in locoregionally advanced carcinoma of head and neck: Results of a prospective randomized trial

(2015) Sarbani Ghosh-Laskar et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data

(2015) Lesley A. Stewart et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis

(2015) Pierre Blanchard et al.   LANCET ONCOLOGY

Docetaxel, cisplatin and 5-fluorouracil induction chemotherapy followed by chemoradiotherapy or chemoradiotherapy alone in stage III–IV unresectable head and neck cancer

(2015) Zoltán Takácsi-Nagy et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Long-term results of a randomized phase III trial of TPF induction chemotherapy followed by surgery and radiation in locally advanced oral squamous cell carcinoma

(2015) Lai-ping Zhong et al.   Oncotarget

Phase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck Cancer

(2014) Ezra E.W. Cohen et al.   JOURNAL OF CLINICAL ONCOLOGY

A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer

(2013) R. Hitt et al.   ANNALS OF ONCOLOGY

Taxane-Cisplatin-Fluorouracil As Induction Chemotherapy in Locally Advanced Head and Neck Cancers: An Individual Patient Data Meta-Analysis of the Meta-Analysis of Chemotherapy in Head and Neck Cancer Group

(2013) Pierre Blanchard et al.   JOURNAL OF CLINICAL ONCOLOGY

Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial

(2013) Robert Haddad et al.   LANCET ONCOLOGY

Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck

(2012) Jay S. Cooper et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Randomized Phase III Trial of Induction Chemotherapy With Docetaxel, Cisplatin, and Fluorouracil Followed by Surgery Versus Up-Front Surgery in Locally Advanced Resectable Oral Squamous Cell Carcinoma

(2012) Lai-ping Zhong et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer

(2012) Arlene A. Forastiere et al.   JOURNAL OF CLINICAL ONCOLOGY

8512 POSTER DISCUSSION A Three-Arm Randomized Trial Comparing Neo-Adjuvant or Concurrent Weekly Cisplatin to Radiotherapy Alone for Locally Advanced Head and Neck Squamous Cell Cancer (HNSCC)

(2011) S. Kumar et al.   EUROPEAN JOURNAL OF CANCER

Concomitant Cisplatin and Hyperfractionated Radiotherapy in Locally Advanced Head and Neck Cancer: 10-Year Follow-Up of a Randomized Phase III Trial (SAKK 10/94)

(2011) Pirus Ghadjar et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

A critical review of methods for the assessment of patient-level interactions in individual participant data meta-analysis of randomized trials, and guidance for practitioners

(2011) D.J. Fisher et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Accelerated radiotherapy and concomitant high dose chemotherapy in non resectable stage IV locally advanced HNSCC: Results of a GORTEC randomized trial

(2011) Jean Bourhis et al.   RADIOTHERAPY AND ONCOLOGY

Concomitant chemoradiation versus radical radiotherapy in advanced squamous cell carcinoma of oropharynx and nasopharynx using weekly cisplatin: a phase II randomized trial

(2010) A. Sharma et al.   ANNALS OF ONCOLOGY

Phase III Study of Radiation Therapy With or Without Cis-Platinum in Patients With Unresectable Squamous or Undifferentiated Carcinoma of the Head and Neck: An Intergroup Trial of the Eastern Cooperative Oncology Group (E2382)

(2010) Harry Quon et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study

(2009) A. Paccagnella et al.   ANNALS OF ONCOLOGY

Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy

(2009) J. L. Lefebvre et al.   JNCI-Journal of the National Cancer Institute

Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial

(2009) Jeffrey S Tobias et al.   LANCET ONCOLOGY

Long-Term Results of a Phase III Randomized Trial of Postoperative Radiotherapy With or Without Carboplatin in Patients With High-Risk Head and Neck Cancer

(2009) Athanassios Argiris et al.   LARYNGOSCOPE

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients

(2009) Jean-Pierre Pignon et al.   RADIOTHERAPY AND ONCOLOGY

Randomized clinical trial of post-operative radiotherapy versus concomitant carboplatin and radiotherapy for head and neck cancers with lymph node involvement

(2008) Séverine Racadot et al.   RADIOTHERAPY AND ONCOLOGY